Background The aim of the study was to evaluate the prevalence, clinical characteristics, and diagnostic importance of nystagmus in children with brain tumors. Methods A nation-wide retrospective review of all children diagnosed with a brain tumor between January the 1st, 2007 and December 31st, 2017, in Denmark. Data is based on information from the Danish Childhood Cancer Registry, hospital records from pediatric- and ophthalmological departments, and records from private ophthalmologists. Results Nystagmus was observed in 13.7% (60/437) of children with a brain tumor. In 50/60 children (83.3%) nystagmus was an incidental finding at the clinical examination and only in 10/60 children (16,7%) were nystagmus noticed by patient/caregivers prior to the clinical examination. In 38/60 children nystagmus was observed before the brain tumor diagnosis, most often (16/38, 42%) the same day as the diagnosis was made. In 22/60 children nystagmus was found after the brain tumor diagnosis (prior to any treatment) with a median of four days (range 0–47) after the brain tumor diagnosis. Nystagmus was most commonly binocular (56/60, 93.3%) and gaze-evoked (43/60, 71.7%). The median number of additional symptoms and/or clinical findings was five (range 0–11). Conclusion Nystagmus is frequent in children with brain tumors and is typically accompanied by other symptoms and clinical signs. However, it is often first recognized by the ophthalmologist late in the time course. Therefore, awareness of nystagmus and the importance to test for gaze-evoked forms might contribute to increased suspicion of brain tumor and thereby faster diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.